Table 1.
Donor
|
|||
---|---|---|---|
Characteristic | 1 | 2 | 3 |
State of shipped hepatocyes | Cryopreserved | Fresh | Cryopreserved |
Lot no. | KQG | MHU-L-092507 | ONQ |
Experimental repetitions (n ) | 2 | 1 | 1 |
Sex | Female | Male | Male |
Age (years) | 38 | 50 | 61 |
Race | Caucasian | Caucasian | Caucasian |
Body mass index | 38.6 | 34.4 | 42.9 |
History of alcohol use | Yes | Yes | Yes |
History of narcotic use | None reported | None reported | None reported |
History of tobacco use | Yes | None reported | Yes |
Relevant medical history | None reported | None reported | None reported |
Relevant chronic medications | None reported | None reported | None reported |
Cause of death | Cerebrovascular accident (stroke) | Head trauma | Head trauma |
Initial viability (%) | 83.8 | 93a | 83.7 |
Viable cell density (cells/mL) | 7.0 × 105 | NA | 7.0 × 105 |
Confluence at 24 hr (%) | 80 | 70 | 50–60 |
Metabolic activityb (pmol/106 cells/min) | |||
Formation of 7-hydroxycoumarin | 49 | N/A | 66 |
Formation of 7-hydroxycoumarin glucuronide | 191 | NA | 247 |
Formation of 7-hydroxycoumarin sulfate | 12 | NA | 47 |
Formation of 6β-hydroxytestosterone | 108 | NA | 60 |
Formation of 4′-methylhydroxytolbutamide | 25 | NA | 18 |
NA, not available.
At time of plating (measured by supplier).
Provided by hepatocyte supplier.